Breaking News Instant updates and real-time market news.

IPXL

Impax

, PSTG

Pure Storage

09:40
08/09/17
08/09
09:40
08/09/17
09:40

Unusually active option classes on open August 9th

Unusual total active option classes on open include: Impax (IPXL), Pure Storage (PSTG), Disney (DIS), iShares South Korea (EWY), Dow Chemical (DOW), SPDR Gold Trust (GLD), Priceline (PCLN), Utilities Sector SPDR (XLU), iPath S&P 500 VIX Short Term Futures (VXX), and JD.com (JD).

IPXL

Impax

PSTG

Pure Storage

DIS

Disney

EWY

iShares MSCI South Korea Index Fund

DOW

Dow Chemical

GLD

SPDR Gold Trust

PCLN

Priceline

$2,049.00

6.36 (0.31%)

XLU

Utilities SPDR

VXX

iPath S&P 500 VIX Short-Term Futures

JD

JD.com

$48.15

0.59 (1.24%)

  • 09

    Aug

  • 10

    Aug

  • 14

    Aug

  • 24

    Aug

IPXL Impax

07/31/17
ADAM
07/31/17
INITIATION
Target $19
ADAM
Hold
Impax initiated with a Hold at Canaccord
Canaccord Genuity analyst Dewey Steadman started Impax Laboratories with a Hold rating and $19 price target. The analyst prefers to wait for a more attractive entry point.
07/18/17
PIPR
07/18/17
UPGRADE
Target $16
PIPR
Neutral
Impax upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst David Amsellem upgraded Impax Laboratories to Neutral and raised his price target for the shares to $16 from $9. The company is now better positioned to return to earnings growth following the approval of an AB-rated generic form of Concerta, Amsellem tells investors in a research note. He sees "ample room" for Impax to gain a "significant foothold" in the Concerta market.
06/16/17
CANT
06/16/17
INITIATION
Target $20
CANT
Overweight
Impax initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Impax Laboratories with an Overweight rating and $20 price target.
06/09/17
JANY
06/09/17
NO CHANGE
Target $25
JANY
Buy
Janney see meaningful upside potential for Collegium after FDA removes Opana
After the FDA requested that Endo (ENDP) remove reformulated Opana ER from the market, Janney Capital analyst Ken Trbovich said that the nearly 500,000 Opana prescriptions filled in the last 12-months will switch to products such as Collegium's (COLL) Xtampza and Impax Laboratories' (IPXL) generic oxymoprhone ER. The news brings "meaningful potential upside" for Collegium, which has already shown through comparative studies that Xtampza has superior abuse-deterrent features, stated Trbovich, who reiterates his Buy rating and $25 fair value estimate on Collegium shares.
PSTG Pure Storage

06/14/17
JMPS
06/14/17
NO CHANGE
JMPS
Pure Storage targets mixed, says JMP Securities
After attending Pure Storage's Analyst Day, JMP Securities analysts John Lucia and Erik Suppiger are encouraged with the company's target of growing revenues at an over 30% CAGR from 2017-2020. However, the analysts say that the company's operating margin guidance of 6%-10% could raise concerns about its profitability.But they believe that the company "is positioning itself to take advantage of growth areas in the market, including next-generation data such as artificial intelligence and machine learning, leading cloud providers in SaaS and IaaS, and enterprise hybrid cloud." The analysts keep a $16 price target and an Outperform rating on the stock.
07/13/17
KEYB
07/13/17
NO CHANGE
KEYB
Pure Storage, Nutanix updates should increase deal sizes, says KeyBanc
KeyBanc analyst Alex Kurtz says new software capabilities announced by Pure Storage (PTSG) and Nutanix (NTNX) in the last month should enable their deal sizes to rise by "at least 30%" in some cases. He keeps Overweight ratings on both stocks.
07/12/17
JEFF
07/12/17
NO CHANGE
Target $125
JEFF
Underperform
IBM price target lowered to $125 from $135 at Jefferies
Jefferies analyst James Kisner lowered his price target for IBM (IBM) to $125 and reiterates an Underperform rating on the shares. While channel checks indicate IBM's Watson platform remains one of the most complete cognitive platforms available in the marketplace today, the "hefty services" component of many artificial intelligence deployments will be a hindrance to adoption, Kisner tells investors in a research note titled "Creating Shareholder Value with AI? Not so Elementary, My Dear Watson." The analyst also believes IBM looks "outgunned in the war" for AI talent and will likely see increasing competition. Kisner adds that his firm believes Nvidia (NVDA) is the biggest beneficiary of ramping AI adoption. He lists Pure Storage (PSTG) and Mellanox (MLNX) as other beneficiaries.
05/23/17
UBSW
05/23/17
NO CHANGE
Target $15
UBSW
Buy
Pure Storage weakness a buying opportunity, says UBS
UBS analyst Steven Milunovich said the recent pullback in Pure Storage has created a buying opportunity and an attractive risk/reward. He believes the current stock price discounts the current risks, while the company has the advantages of the flash market being hot and its differentiated hardware and software. Milunovich reiterated his Buy rating and $15 price target on Pure Storage shares.
DIS Disney

08/09/17
FBCO
08/09/17
NO CHANGE
Target $120
FBCO
Outperform
Disney price target lowered to $120 from $125 at Credit Suisse
Credit Suisse analyst Omar Sheikh lowered his price target for Disney to $120 from $125, while reiterating an Outperform rating on the shares. The analyst believes Disney's decision to shift its distribution strategy toward a direct to consumer model leans into the accelerating shifts in video consumption. Ahead is now a period when EPS/free cash flow growth will be diluted by investment, he notes, adding that he believes the company is laying the groundwork for a "stronger future strategically," not least by putting ESPN in a stronger position to successfully renew key sports rights in 2021/2022.
08/09/17
NEED
08/09/17
NO CHANGE
NEED
Hold
Needham applauds BAMTech acquisition by Disney
Needham analyst Laura Martin is lowering her 2018 estimates for Disney (DIS), but applauds the BAMTech acquisition as a fast-pass way to escape the U.S. TV-bundle box, albeit expensive as the former said it would be modestly dilutive for 2 years. The analyst believes that every content company must follow CBS (CBS) into the direct-to-consumer channel business to maintain growth. Rather than build it, Disney bought this capability which should accelerate time to market, Martin adds. The analyst reiterates a Hold rating on Disney's shares.
08/09/17
UBSW
08/09/17
NO CHANGE
Target $190
UBSW
Buy
UBS sees little to no impact to Netflix from Disney streaming service launch
UBS analyst Doug Mitchelson noted Disney (DIS) announced plans to launch its own streaming video service in 2019 and said it will not enter into any new licenses with Netflix (NFLX). Disney management has said they still view Netflix as a valuable partner, Mitchelson pointed out. The analyst sees little to no impact to Netflix, noting Disney's offerings will not launch for two years, Disney is adding original content, and he believes the streaming video marketplace will continue to grow. Mitchelson reiterated his Buy rating and $190 price target on Netflix shares.
08/09/17
MSCO
08/09/17
NO CHANGE
Target $210
MSCO
Overweight
Netflix Overweight thesis remains intact, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said Netflix's (NFLX) strategy to build its own vertically integrated global content brand will mitigate the loss of Disney (DIS). Swinburne expects some impact to Netflix's second half 2019 when Disney rolls off but said his Overweight thesis and $210 price target remain intact.
EWY iShares MSCI South Korea Index Fund

DOW Dow Chemical

03/06/17
JEFF
03/06/17
UPGRADE
Target $75
JEFF
Buy
Dow Chemical upgraded to Buy from Hold at Jefferies
Jefferies analyst Laurence Alexander upgraded Dow Chemical (DOW) to Buy and raised his price target for the shares to $75 from $65. The analyst believes the merger with DuPont (DD) is likely to close in the near future and that only "cautious enthusiasm" is being priced into the shares. Capitalizing on the targeted cost synergies implies 11%-17% potential upside in the stocks, Alexander tells investors in a research note.
03/06/17
JEFF
03/06/17
UPGRADE
Target $96
JEFF
Buy
DuPont upgraded to Buy from Hold at Jefferies
Jefferies analyst Laurence Alexander upgraded DuPont (DD) to Buy and raised his price target for the shares to $96 from $83. The analyst believes the merger with Dow Chemical (DOW) is likely to close in the near future and that only "cautious enthusiasm" is being priced into the shares. Capitalizing on the targeted cost synergies implies 11%-17% potential upside in the stocks, Alexander tells investors in a research note. The analyst this morning also upgraded Dow Chemical to Buy.
01/27/17
FBCO
01/27/17
NO CHANGE
Target $66
FBCO
Outperform
Dow Chemical price target raised to $66 from $61 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for Dow Chemical to $66 from $61 as "strong" fundamentals and cost-cutting execution drove a Q4 beat. Heading into 2017, the analyst is encouraged by the company's ability to drive profit growth through ongoing cost-cutting initiatives, streamlined execution of Dow Corning cost synergies and a timely ramp of the project backlog, which should more than offset some risk regarding a volatile macro and FX. He reiterates an Outperform rating on the shares.
03/03/17
JPMS
03/03/17
NO CHANGE
Target $128
JPMS
Overweight
EU approvals of other ag deals may narrow Monsanto deal spread, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas said commentary from the CEOs of DuPont (DD) and Syngenta (SYT) and press reports from Europe suggest that their deals with Dow Chemical (DOW) and ChemChina, respectively, are likely to be approved. Approvals from Europe for those deals may "trigger a meaningful closing of the arbitrage spread" in Monsanto (MON) shares versus Bayer's (BAYRY) offer price, Zekauskas tells investors. He recommends buying Monsanto shares at current levels for this reason, adding that he believes the shares would only fall about 2.5%, or down to $112, in the event of the Bayer deal falling through. Zekauskas keeps an Overweight rating and $128 price target on Monsanto shares, which closed yesterday at just below $115 per share.
GLD SPDR Gold Trust

PCLN Priceline
$2,049.00

6.36 (0.31%)

08/09/17
FBCO
08/09/17
NO CHANGE
Target $2070
FBCO
Outperform
Priceline price target lowered to $2070 from $2150 at Credit Suisse
Credit Suisse analyst Paul Bieber lowered his price target for Priceline to $2070 from $2150 following mixed quarterly results and given a disappointing 3Q room night growth outlook. While the analyst thinks Priceline conservatism is a partial driver of the outlook, commentary on marketing ROI and competition in Asia are likely to weigh on sentiment until the company can demonstrate improved room night growth and/or continued gross profit and EPS upside versus guidance. Bieber reiterates an Outperform rating on the shares.
08/09/17
COWN
08/09/17
NO CHANGE
Target $2250
COWN
Outperform
Priceline results solid and guidance follows trend, says Cowen
Cowen analyst Kevin Kopelman noted Priceline failed to beat expectations with its operating metrics for the first time since 2012, but Q2 results were still solid and Q3 guidance was in line with trends. Kopeleman left his estimates intact and reiterated his Outperform rating and $2,250 price target on Priceline shares.
08/09/17
LEHM
08/09/17
NO CHANGE
Target $2100
LEHM
Overweight
Priceline shares due for 'breather' after 40% rally, says Barclays
Barclays analyst Ross Sandler says shares of Priceline are due for a "breather" after the company guided below expectations for the second straight quarter. The analyst notes the stock is up 40% year-to-date. Sandler recommends adding to positions "selectively" on weakness and keeps an Overweight rating on the name. He upped his price target for Priceline to $2,100 from $2,050.
08/09/17
MACQ
08/09/17
NO CHANGE
Target $2200
MACQ
Outperform
Priceline price target to $2,200 due to ongoing momentum at Macquarie
Macquarie analyst Matthew Brooks remains positive on Priceline following the Q2 beat and raised its price target to $2,200 from $2,000 on this Outperform rated stock The analyst said continued acceleration in new listings on Bookings.com should continue to drive shares higher and expects the company to beat Q3 EBITDA guidance of $2,030M-$2,130M.
XLU Utilities SPDR

VXX iPath S&P 500 VIX Short-Term Futures

JD JD.com
$48.15

0.59 (1.24%)

06/08/17
DBAB
06/08/17
NO CHANGE
Target $151
DBAB
Buy
Alibaba growth 'conceivably higher' than JD.com, says Deutsche Bank
Deutsche Bank analyst Alan Hellawell says Alibaba's (BABA) "impressive" FY18 revenue growth guidance of 45%-49% takes the company to a growth trajectory "conceivably higher" than JD.com (JD). The analyst sees further momentum for Alibaba shares and reiterates a Buy rating on the name with a $181 price target.
05/09/17
05/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) upgraded to Neutral from Underweight at Atlantic Equities. 2. CDW (CDW) upgraded to Outperform from Neutral at Baird with analyst Jayson Noland saying he believes the company is well positioned to take market share given its breadth, scale, culture, and ability to execute. Noland raised his price target to $71 from $63 on CDW shares. 3. LyondellBasell (LYB) upgraded to Buy from Hold at Vertical Research with analyst Kevin McCarthy citing recent share weakness. He believes risk/reward is turning more favorable given the likelihood of a more balanced and opportunistic approach to M&A, a "spring loaded" operational profile with various maintenance and expansion projects now complete, and attractive valuation with the highest dividend yield among US chemical stocks at 4.2%. 4. DXC Technology (DXC) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst James Schneider saying DXC has sustained earnings momentum driven by margin expansion and cost synergies and raised estimates to reflect upside to synergy targets and share repurchases. 5. JD.com (JD) upgraded to Market Perform from Underperform at Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/09/17
PACS
05/09/17
NO CHANGE
PACS
JD.com price target raised to $45 from $40 at Pacific Crest
Pacific Crest analyst Hans Chung raised his price target on JD.com after the company reported stronger than expected results and provided revenue guidance that he views as "strong." The analyst expects the company's margins to continue to increase significantly for the rest of the year, and he keeps an Overweight rating on the shares.
05/09/17
BERN
05/09/17
UPGRADE
BERN
Market Perform
JD.com upgraded to Market Perform from Underperform at Bernstein

TODAY'S FREE FLY STORIES

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Recommendations
Medtronic, Dexcom, TNDM analyst commentary  »

Medtronic challenges in…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

TWX

Time Warner

$101.67

-0.44 (-0.43%)

, T

AT&T

$37.63

0.045 (0.12%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Periodicals
Time Warner-AT&T deal questioned by Brazil regulator, Bloomberg says »

Brazils antitrust…

TWX

Time Warner

$101.67

-0.44 (-0.43%)

T

AT&T

$37.63

0.045 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FCX

Freeport McMoRan

$15.37

0.6399 (4.34%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Technical Analysis
Technical View: Freeport McMoRan breaks through top of recent range »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$18.92

3.23 (20.59%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Downgrade
DSW rating change  »

DSW downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RDFN

Redfin

$27.56

0.86 (3.22%)

, EGN

Energen

$50.21

0.65 (1.31%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on the…click here.

RDFN

Redfin

$27.56

0.86 (3.22%)

EGN

Energen

$50.21

0.65 (1.31%)

PXD

Pioneer Natural

$128.63

0.69 (0.54%)

RVNC

Revance

$22.70

-0.45 (-1.94%)

PCRX

Pacira

$35.75

-0.05 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

  • 25

    Sep

  • 02

    Nov

MYL

Mylan

$30.44

-0.28 (-0.91%)

, BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MYL

Mylan

$30.44

-0.28 (-0.91%)

BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

GMRE

Global Medical REIT

$8.38

-0.6 (-6.68%)

NXTM

NxStage Medical

$29.11

-0.14 (-0.48%)

FMS

Fresenius Medical

$46.69

0.37 (0.80%)

HKMPY

Hikma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 03

    Sep

  • 06

    Sep

  • 08

    Sep

  • 15

    Sep

  • 09

    Oct

BABA

Alibaba

$171.47

2.22 (1.31%)

, VMW

VMware

$98.97

1.96 (2.02%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

BABA

Alibaba

$171.47

2.22 (1.31%)

VMW

VMware

$98.97

1.96 (2.02%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

EL

Estee Lauder

$106.53

0.05 (0.05%)

TPX

Tempur Sealy

$62.42

0.91 (1.48%)

WUBA

58.com

$63.80

-0.34 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

FEYE

FireEye

$13.77

-0.21 (-1.50%)

10:25
08/22/17
08/22
10:25
08/22/17
10:25
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

VMW

VMware

$99.09

2.08 (2.14%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:23
08/22/17
08/22
10:23
08/22/17
10:23
Hot Stocks
Deutsche ups VMware on slower than expected enterprise move to public cloud »

Deutsche Bank upgraded…

VMW

VMware

$99.09

2.08 (2.14%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

ORCL

Oracle

$49.11

0.205 (0.42%)

RHT

Red Hat

$102.19

-0.465 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

  • 05

    Sep

TWX

Time Warner

$101.80

-0.31 (-0.30%)

, T

AT&T

$37.77

0.1899 (0.51%)

10:21
08/22/17
08/22
10:21
08/22/17
10:21
Periodicals
Time Warner, AT&T deal questioned by Brazil antitrust agency, Bloomberg says »

Shares of Time Warner…

TWX

Time Warner

$101.80

-0.31 (-0.30%)

T

AT&T

$37.77

0.1899 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SHLD

Sears

$8.55

-0.1 (-1.16%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:19
08/22/17
08/22
10:19
08/22/17
10:19
Hot Stocks
Sears jumps after announcing latest licensing deals for Kenmore, DieHard brands »

Shares of Sears Holdings…

SHLD

Sears

$8.55

-0.1 (-1.16%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

LOW

Lowe's

$75.27

1.42 (1.92%)

HD

Home Depot

$150.33

1.13 (0.76%)

BBY

Best Buy

$61.37

0.9185 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 29

    Aug

  • 19

    Sep

  • 21

    Nov

$NSD

NASDAQ Market Internals

10:17
08/22/17
08/22
10:17
08/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PULM

Pulmatrix

$1.67

-0.03 (-1.76%)

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Hot Stocks
Pulmatrix patent for respirable tiotropium dry powders posted to USPTO site 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/22/17
08/22
10:15
08/22/17
10:15
General news
U.S. Richmond Fed manufacturing index was flat at 14 in August »

U.S. Richmond Fed…

AVGO

Broadcom

$249.62

0.25 (0.10%)

10:10
08/22/17
08/22
10:10
08/22/17
10:10
Options
Bullish option play in Broadcom ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CARB

Carbonite

$19.10

-0.15 (-0.78%)

10:05
08/22/17
08/22
10:05
08/22/17
10:05
Hot Stocks
Carbonite annonces strategic referral deal with Code42 »

Carbonite announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBIZ

Century Biz Services

, NJR

New Jersey Resources

$43.10

-0.1 (-0.23%)

10:05
08/22/17
08/22
10:05
08/22/17
10:05
Conference/Events
CFA Society of Minnesota to hold a conference »

2017 Intellisight…

CBIZ

Century Biz Services

NJR

New Jersey Resources

$43.10

-0.1 (-0.23%)

HMN

Horace Mann

$37.30

0.25 (0.67%)

XEL

Xcel Energy

$49.15

-0.06 (-0.12%)

DGII

Digi International

$8.85

0.25 (2.91%)

EMCI

EMC Insurance

$27.59

-0.01 (-0.04%)

MCS

Marcus

$24.75

0.25 (1.02%)

GIS

General Mills

$57.39

0.1 (0.17%)

GGG

Graco

$113.09

0.12 (0.11%)

INWK

InnerWorkings

$10.32

-0.12 (-1.15%)

WGO

Winnebago

$34.70

0.1 (0.29%)

CPLA

Capella Education

$67.15

0.15 (0.22%)

TECH

Bio-Techne

$118.49

0.59 (0.50%)

NOG

Northern Oil and Gas

$0.98

-0.0188 (-1.88%)

CHFS

CHF Solutions

$0.71

-0.0115 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 13

    Sep

  • 14

    Sep

  • 25

    Sep

  • 27

    Sep

  • 28

    Sep

10:01
08/22/17
08/22
10:01
08/22/17
10:01
General news
Richmond Fed Manufacturing Index Level data reported »

August Richmond Fed…

FIT

Fitbit

$5.28

0.2236 (4.42%)

10:00
08/22/17
08/22
10:00
08/22/17
10:00
Options
Healthy option activity in FitBit as shares advance »

Healthy option activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

WMT

Wal-Mart

$80.07

0.36 (0.45%)

, ORLY

O'Reilly Automotive

$197.80

-0.12 (-0.06%)

09:56
08/22/17
08/22
09:56
08/22/17
09:56
Hot Stocks
Trump Effect: Wal-Mart, others set to benefit if Hispanic spending bounces back »

Jefferies analyst Andy…

WMT

Wal-Mart

$80.07

0.36 (0.45%)

ORLY

O'Reilly Automotive

$197.80

-0.12 (-0.06%)

ELF

e.l.f. Beauty

$22.19

-0.88 (-3.81%)

ULTA

Ulta Beauty

$234.21

-9.99 (-4.09%)

JACK

Jack in the Box

$96.37

-0.49 (-0.51%)

FL

Foot Locker

$31.85

0.033 (0.10%)

MUSA

Murphy USA

$67.26

0.86 (1.30%)

TGT

Target

$56.55

-0.01 (-0.02%)

WING

Wingstop

$34.87

0.11 (0.32%)

VVV

Valvoline

$21.45

0.1 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 16

    Nov

  • 20

    Feb

FEYE

FireEye

$13.77

-0.21 (-1.50%)

09:56
08/22/17
08/22
09:56
08/22/17
09:56
Recommendations
FireEye analyst commentary  »

FireEye product customer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

FOSL

Fossil

$7.18

-0.31 (-4.14%)

09:55
08/22/17
08/22
09:55
08/22/17
09:55
Options
Fossil put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.32

0.59 (4.01%)

, M

Macy's

$20.10

0.565 (2.89%)

09:55
08/22/17
08/22
09:55
08/22/17
09:55
Options
Early notable gainers among liquid option names on August 22nd »

Notable gainers among…

FCX

Freeport McMoRan

$15.32

0.59 (4.01%)

M

Macy's

$20.10

0.565 (2.89%)

SWN

Southwestern Energy

$5.27

0.085 (1.64%)

FL

Foot Locker

$31.78

-0.0429 (-0.13%)

VRTX

Vertex

$149.01

0.88 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

AGCO

AGCO

$67.08

-0.01 (-0.01%)

09:52
08/22/17
08/22
09:52
08/22/17
09:52
Conference/Events
AGCO management to meet with Credit Suisse »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.